Pages that link to "Q35579407"

The following pages link to Principles and clinical application of assessing alterations in renal elimination pathways. (Q35579407):

Displaying 32 items.

• Oseltamivir in seasonal, avian H5N1 and pandemic 2009 A/H1N1 influenza: pharmacokinetic and pharmacodynamic characteristics. (Q30394541) (← links)
• A survey of renal impairment pharmacokinetic studies for new oncology drug approvals in the USA from 2010 to early 2015: a focus on development strategies and future directions (Q30491777) (← links)
• Postnatal Maturation of the Glomerular Filtration Rate in Conventional Growing Piglets As Potential Juvenile Animal Model for Preclinical Pharmaceutical Research (Q33849614) (← links)
• Determining the mechanisms underlying augmented renal drug clearance in the critically ill: use of exogenous marker compounds (Q34739945) (← links)
• Renal function, bisphenol A, and alkylphenols: results from the National Health and Nutrition Examination Survey (NHANES 2003-2006) (Q34834681) (← links)
• Glomerular filtration rate (GFR) determination via individual kinetics of the inulin-like polyfructosan sinistrin versus creatinine-based population-derived regression formulae (Q34856938) (← links)
• Pharmacokinetics ofp-Aminohippuric Acid and Inulin in Rabbits with Aristolochic Acid Nephropathy (Q35070926) (← links)
• Null mutation of the nicotinamide adenine dinucleotide phosphate-oxidase subunit p67phox protects the Dahl-S rat from salt-induced reductions in medullary blood flow and glomerular filtration rate (Q35079456) (← links)
• Population pharmacokinetics of fluconazole in critically ill patients receiving continuous venovenous hemodiafiltration: using Monte Carlo simulations to predict doses for specified pharmacodynamic targets (Q35598414) (← links)
• Influence of morbid obesity on the single-dose pharmacokinetics of daptomycin (Q35912780) (← links)
• Anti-factor Xa activity of enoxaparin administered at prophylactic dosage to patients over 75 years old (Q36102602) (← links)
• Effect of impaired renal function on the pharmacokinetics of tomopenem (RO4908463/CS-023), a novel carbapenem (Q36744822) (← links)
• Appropriateness of drug dose and frequency in patients with renal dysfunction in a tertiary care hospital: A cross-sectional study (Q36969326) (← links)
• Medications in the kidney (Q37198832) (← links)
• Progression of glomerular filtration rate reduction determined in conscious Dahl salt-sensitive hypertensive rats (Q37251235) (← links)
• Pharmacokinetics and dosage adjustment in patients with renal dysfunction. (Q37526589) (← links)
• Renal clearance in drug discovery and development: molecular descriptors, drug transporters and disease state (Q37740151) (← links)
• Monitoring renal function: measured and estimated glomerular filtration rates - a review (Q37750515) (← links)
• A Review of the Clinical Pharmacokinetics and Pharmacodynamics of Varenicline for Smoking Cessation (Q37807401) (← links)
• Clearance and beyond: the complementary roles of GFR measurement and injury biomarkers in acute kidney injury (AKI). (Q37900798) (← links)
• Is antiarrhythmic treatment in the elderly different? a review of the specific changes (Q37910895) (← links)
• Does Secretory Clearance Follow Glomerular Filtration Rate in Chronic Kidney Diseases? Reconsidering the Intact Nephron Hypothesis. (Q38694525) (← links)
• Organic anion transporter OAT1 is involved in renal handling of citrulline (Q39858796) (← links)
• Effect of dronedarone on renal function in healthy subjects. (Q42951307) (← links)
• Reversible elevations of serum creatinine levels but no effect on glomerular filtration during treatment with the direct thrombin inhibitor AZD0837. (Q43036231) (← links)
• Drug dosing consideration in patients with acute and chronic kidney disease-a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). (Q44969186) (← links)
• Pharmacokinetic significance of renal OAT3 (SLC22A8) for anionic drug elimination in patients with mesangial proliferative glomerulonephritis. (Q46772973) (← links)
• Effect of Cobicistat on Glomerular Filtration Rate in Subjects With Normal and Impaired Renal Function (Q55056316) (← links)
• GFR may not accurately predict aspects of proximal tubule drug handling (Q59621090) (← links)
• The impact of frailty on pharmacokinetics in older people: using gentamicin population pharmacokinetic modeling to investigate changes in renal drug clearance by glomerular filtration (Q61828129) (← links)
• Implications of augmented renal clearance in critically ill patients (Q64129339) (← links)
• Mechanistic Population Pharmacokinetic Model of Oseltamivir and Oseltamivir Carboxylate Accounting for Physiological Changes to Predict Exposures in Neonates and Infants (Q92762275) (← links)